Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic gene expression signature for high-grade serous ovarian cancer

27 May 2020

Abstract excerpt

BACKGROUND: Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies widely between patients. There are no well-established, gene expression signatures associated with prognosis. The aim of this study was to develop a robust prognostic signature for OS in patients with HGSOC. PATIENTS AND METHODS: Expression of 513 genes, selected from a meta-analysis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Ferroptosis and cancer prognosis
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32473302
DOI: 10.1016/j.annonc.2020.05.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic gene expression signature for high-grade serous ovarian cancerPMID 32473302Read ↗

The molecular prognostic score , a classifier for risk stratification of high-grade serous ovarian cancerSemantic proximity Read ↗

The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancerSemantic proximity Read ↗

A Nine-Immune-Related Gene Prognostic Signature for Predicting Outcomes in High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Novel gene signatures for prognosis prediction in ovarian cancerSemantic proximity Read ↗

Prognostic and predictive value of a mRNA signature in high-grade serous ovarian carcinoma with an integrated computation analysisSemantic proximity Read ↗

Screening of Prognostic Molecular Markers and Establishment of Prognostic Model for G-protein Coupled Receptor-Related Genes in Epithelial Ovarian Serous Cancer Based on Machine Learning MethodSemantic proximity Read ↗

Investigating prognostic biomarkers and tumour suppressor biology in high grade serous ovarian cancerSemantic proximity Read ↗

Development of a novel transcription factors-related prognostic signature for serous ovarian cancerSemantic proximity Read ↗

Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.Semantic proximity Read ↗

Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosisSemantic proximity Read ↗

Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.Semantic proximity Read ↗

Analyzing the extracellular matrix-dominated immune landscape of high-grade serous ovarian cancer to determine prognosis and guide therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.